The insurance subsidiary of financial services provider Fubon has acquired a 0.65% stake in Tiger Global’s XV fund after a similar deal for its IV vehicle earlier this year.

Boehringer Ingelheim Venture Fund and Pierre Fabre have made capital commitments to Advent France Biotechnology’s second fund.

SBI Ven Capital’s newly formed joint venture with Sygnum and Azimut will take part in crypto-oriented deals covering areas such as DLT and decentralised finance.

The venture firm hired new director Asif Giga, who has worked at corporate VC units Ericsson Ventures, Experian Ventures and Singtel Innov8 Ventures.

The firm has signed up Facebook, Airbnb, Carousell, Grab and Stripe for a first fund which has reached a $21.9m close.

Q&A with Andrew Casey, corporate development deal lead, Vanguard Strategic Business Development

Rob Woodman, formerly a senior partner at Takeda’s CVC unit and head of its Genesis Labs incubator, will lead venture firm Panakès Partners’ biotech investment activities.

Vijay Reddy, formerly an AI and deeptech-focused partner at Intel Capital, has departed from its parent company and joined venture firm Clear Ventures in a similar position.

Sanofi, Axa, Aviva, Pro BTP and CNP Assurances were among the backers of the vehicle, which will focus on biotech investments.

Fifth Wall hopes to close its climate technology-focused fund at $500m having secured capital from Invitation Homes and Ivanhoé Cambridge.